MCPIR and CfC Reschedule Cannabis Cultivation Day for 2026
Cannabis cultivation education 2026 is shifting as MCPIR and CfC bring cultivation day back to its original timing. This change aims to enhance medical cannabis cultivation training and improve product quality standards. Cultivators and clinicians alike…
CBD Reviews: Benefits, Efficacy, and Product Analysis for Informed Choices
CBD product evaluation challenges impact clinicians and patients alike. This article highlights the importance of clinical evidence and patient guidance. Understanding product quality and regulatory developments is essential for informed CBD use.
Study: Clinical evidence review for Cannabidiol
This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as…
Flipping the Switch to LED Grow Lights: Adjustments and Refinements
LED grow lights cannabis cultivation is transforming medical cannabis production by influencing cannabinoid and terpene profiles. Adjustments and refinements in cultivation methods are essential to maintain product consistency and therapeutic efficacy.…
Medipharm Labs Reports 43% Growth in International Medical Cannabis Revenue for 2025
Medipharm Labs reports a 43% growth in pharmaceutical-grade cannabis revenue in 2025. This growth highlights expanding international medical cannabis markets. The pharmaceutical-grade cannabis revenue growth reflects increasing global acceptance of…
Air Canada Employee Charged with Trafficking Cannabis – Clinical Insights
This cannabis trafficking case highlights ongoing challenges in cannabis supply chain integrity that impact patient access to regulated medical cannabis. The case involves illicit distribution outside Canada's regulated framework. It underscores the…
LABS: International Medical Cannabis Revenue Growth and Margin Improvement in 2025
International medical cannabis revenue growth reached 8% in 2025, reflecting expanding patient access and improved market dynamics. This growth indicates better product quality and healthcare economics in regulated programs. Understanding international…
Solving the Heavy Metal Testing Compliance Headache in Multi-State Cannabis Labs
Heavy metal contamination cannabis poses serious health risks, especially for medical users with high consumption. Multi-state cannabis labs face compliance challenges due to inconsistent regulations. Addressing these issues is critical to maintaining…
These 5 N.J. Smoke Shops Ordered to Shut Down Amid Cannabis Crackdown
Unregulated cannabis products risks are a major concern as five N.J. smoke shops were ordered to shut down in a city crackdown. These unauthorized shops pose significant patient safety risks due to lack of quality control. Patients should be advised to…
OP-ED: Bias and Dysfunction in Cannabis Regulation at CBC
2026 cannabis regulatory dysfunction is creating challenges for patient access to quality cannabis medicines. Regulatory instability impacts product testing and licensing consistency. Clinicians face uncertainty recommending cannabis therapeutically amid…